Caviton Tablet

Introduction

Caviton Tablet 5 mg is a synthetic derivative of the alkaloid vincamine, extracted from the periwinkle plant. It is commonly used as a neuroprotective agent and cognitive enhancer, particularly in the treatment of cerebrovascular disorders and conditions related to impaired blood flow to the brain. Caviton Tablet 5 mg is popular for improving memory, cognitive function, and cerebral metabolism.

Uses

Caviton Tablet 5 mg is used for:

Treating cerebrovascular insufficiency and enhancing cerebral circulation.
Improving cognitive function and memory in patients with Alzheimer's disease, dementia, and other neurodegenerative conditions.
Providing neuroprotection following ischemic stroke and brain trauma.
Enhancing mental clarity, focus, and attention.

Brand Name	Caviton
Type	Tablet
Weight	5 mg
Generic	Vinpocetine
Manufacturer	Opsonin Pharma Ltd.
Available in	English বাংলা

Mechanism of Action

Caviton Tablet 5 mg works primarily by inhibiting phosphodiesterase (PDE) enzymes and modulating ion channels. It increases cerebral blood flow by relaxing smooth muscle in blood vessels and improving microcirculation in the brain. Additionally, it enhances the utilization of glucose and oxygen in the brain and has antioxidant properties, protecting neurons from oxidative stress.

How Long Does It Take to Work?

The onset of action for Caviton Tablet 5 mg is typically within 1 to 2 hours after oral administration. It may take several weeks of consistent use for the full cognitive-enhancing effects to be realized in chronic conditions.

Absorption

Caviton Tablet 5 mg is absorbed rapidly after oral administration. It has a bioavailability of around 6.7% due to significant first-pass metabolism in the liver. Peak plasma concentrations are usually reached within 1 to 2 hours after ingestion.

Route of Elimination

Caviton Tablet 5 mg is primarily metabolized in the liver to its main metabolite, apovincaminic acid. It is then excreted mainly through the kidneys as metabolites. A small fraction of the drug is excreted unchanged in the urine.

Dosage

Tablet: 1-2 tablets thrice daily, the maintenance dose is 1 tablet thrice daily.

IM Injection: Daily dose of 20-40 mg are to be given until improvement of symptoms is reached (for not longer than 10 days) then oral treatment should be applied. If this regimen fails, infusion treatment should be started.

IV Infusion: The daily starting dose is 20 mg in slow drip infusion (2 ampoules in 500-1000 ml infusion solution). This dose can be increased to 1 mg/kg body weight during 3 to 4 days. Treatment should be continued for 10-14 days depending on the tolerance of the patients and the dose should be gradually reduced before discontinuation of treatment.

The typical dosage of Caviton Tablet 5 mg for cognitive enhancement and neuroprotection ranges from 5 mg to 30 mg per day, divided into two to three doses. For cerebrovascular insufficiency, doses of up to 20 mg three times daily may be recommended. Dosage should be individualized based on patient needs and clinical response.

Administration

Caviton Tablet 5 mg is administered orally in the form of tablets or capsules. It is recommended to take the medication with food to enhance absorption. The tablets should be swallowed whole with a glass of water, without crushing or chewing.

Side Effects

Common side effects include:

Headache
Dizziness
Nausea
Gastrointestinal upset

Less common but more severe side effects may include:

Allergic reactions (rash, itching, swelling)
Flushing
Insomnia or sleep disturbances

Toxicity

Caviton Tablet 5 mg is generally well-tolerated at therapeutic doses. In cases of overdose, symptoms may include nausea, dizziness, and hypotension. Treatment is supportive and may include discontinuation of the drug and symptomatic care.

Precautions

Precautions should be taken in patients with:

Pre-existing hypotension
Bleeding disorders or those taking anticoagulants
Pregnant or breastfeeding women (use with caution)
Cardiac arrhythmias

Regular monitoring of blood pressure and overall health is recommended during prolonged use.

Interaction

Caviton Tablet 5 mg may interact with:

Anticoagulants and antiplatelet agents: Increased risk of bleeding.
Antihypertensive drugs: Additive effects may lead to excessive lowering of blood pressure.
CYP450 enzyme inhibitors: May alter the metabolism of Caviton Tablet 5 mg, affecting its efficacy and safety.

Disease Interaction

Caviton Tablet 5 mg should be used cautiously in patients with:

Bleeding disorders or a history of stroke
Severe hypotension
Arrhythmias or heart conditions

Drug Interaction

Caviton Tablet 5 mg may interact with several types of medications, including:

Anticoagulants and antiplatelet drugs: Increased risk of bleeding due to additive effects.
Blood pressure medications: May cause excessive hypotension when used concurrently.
Enzyme inhibitors or inducers: May affect the metabolism of Caviton Tablet 5 mg, leading to altered blood levels.

Food Interactions

Caviton Tablet 5 mg is best taken with food to enhance absorption. There are no significant food interactions, but a balanced diet may improve overall therapeutic outcomes.

Pregnancy Use

Caviton Tablet 5 mg is not recommended for use during pregnancy due to insufficient evidence regarding its safety. It should only be used if the potential benefits outweigh the risks to the fetus.

Lactation Use

There is limited information on the excretion of Caviton Tablet 5 mg in breast milk. It is generally recommended to avoid its use during lactation unless absolutely necessary, as the effects on the nursing infant are unknown.

Acute Overdose

In cases of acute overdose, symptoms may include nausea, vomiting, dizziness, and hypotension. Treatment is supportive and may involve discontinuation of the drug, hydration, and monitoring of vital signs. Seek medical attention if overdose occurs.

Contraindication

Caviton Tablet 5 mg is contraindicated in patients with:

Severe hypotension
Recent hemorrhagic stroke
Known hypersensitivity to Caviton Tablet 5 mg or its components

Use Direction

Take Caviton Tablet 5 mg exactly as prescribed by your healthcare provider. Adhere to the recommended dosage and schedule. It is important not to abruptly discontinue the medication without consulting a healthcare provider, especially in cases of long-term use.

Storage Conditions

Store Caviton Tablet 5 mg at room temperature, between 20°C and 25°C (68°F and 77°F). Keep it away from excessive heat, light, and moisture. Ensure it is stored out of reach of children and pets.

Volume of Distribution

The volume of distribution of Caviton Tablet 5 mg is approximately 3.4 L/kg, indicating its moderate distribution into body tissues and fluids.

Half Life

The elimination half-life of Caviton Tablet 5 mg is approximately 2 to 4 hours. Due to this short half-life, it is typically dosed multiple times per day to maintain therapeutic levels.

Clearance

Caviton Tablet 5 mg is primarily cleared by hepatic metabolism, with renal excretion of its metabolites. Clearance rates may vary depending on liver and kidney function. In individuals with impaired hepatic or renal function, dose adjustments may be necessary.

See in details version Caviton Tablet 5 mg also Caviton Tablet 5 mg in bangla